Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 551 of 5804
-
Could microwaves replace mammograms? new study tests safer, more comfortable breast cancer screening
Diagnosis Recruiting nowThis is an open, multicentric, interventional, prospective, non-randomized clinical investigation. The first aim of the study is to confirm that MammoWave reaches sensitivity\>75% and specificity\>90% in breast cancer (BC) detection on 10.000 volunteers undergoing regular screeni…
Phase: NA • Sponsor: Umbria Bioengineering Technologies • Aim: Diagnosis
Last updated Jun 27, 2026 12:33 UTC
-
Could a second round of radiation boost survival in returning brain tumors?
Disease control Recruiting nowDespite comprehensive multimodal treatment of newly diagnosed glioblastoma, almost all patients suffer from tumour relapse. Currently, no standard of care exists to treat these tumour relapses. Treatment options include repeated surgery (if feasible), systemic therapy (bevacizuma…
Phase: PHASE3 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 27, 2026 13:04 UTC
-
New heart valve trial offers hope for thousands with stiff heart valves
Disease control ENROLLING_BY_INVITATIONThe objective of ENVISION is to evaluate the safety and effectiveness of the Navitor Transcatheter Aortic Valve Implantation (TAVI) System for treating patients with symptomatic, severe native aortic stenosis who are considered intermediate or low risk for surgical mortality. Th…
Phase: NA • Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Eye drops could replace needles for Diabetes-Related vision loss
Disease control CompletedThe primary objective of this study is to evaluate the efficacy and safety of the topical ophthalmic administration of OCS 01 as compared to Vehicle in participants with Diabetic Macular Edema (DME).
Phase: PHASE3 • Sponsor: Oculis • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
New drug duo aims to tame aggressive lymphoma without chemo
Disease control OngoingTo learn if obinutuzumab in combination with CC-99282 can help to control previously untreated, high tumor burden FL
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
HIIT may boost heart health after stroke, new trial shows
Disease control OngoingObjective. To assess the effect of innovative "High-Intensity Interval Training" (HIIT) on Heart Rate Variability, a strong biomarker of positive outcome after stroke. Design. A randomized controlled study with blinded assessment of the main criteria. Population. NIHSS\<20 post…
Phase: NA • Sponsor: Hôpital Léon Bérard • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could cooling Babies' brains after mild birth injury boost IQ?
Disease control Recruiting nowThe goal of this randomised control trial is to establish the safety and efficacy of whole-body hypothermia for babies with mild hypoxic ischaemic encephalopathy, inform national and international guidelines, and establish uniform practice across the NHS. The main questions it a…
Phase: PHASE3 • Sponsor: Imperial College London • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New blood test could end guesswork in liver cancer diagnosis
Diagnosis Recruiting nowIt is sometimes difficult to precisely understand whether a primary liver cancer is a hepatocellular carcinoma or a cholangiocarcinoma. The researchers will develop and validate a liquid biopsy, based on exosomal content analysis and powered by machine learning, to help clinician…
Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jul 09, 2026 00:00 UTC
-
New TB vaccine trial aims to stop infection before it starts
⭐️ VACCINE ⭐️ OngoingTuberculosis (TB) is an infection caused by bacteria passed from one person to another through the air when an infected person for instance coughs, speaks, or sneezes. This study tests the safety and vaccine-induced immune response of a new preventive TB vaccine called H107e/CAF®…
Phase: PHASE1 • Sponsor: Statens Serum Institut • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 11:00 UTC
-
New hope for Hard-to-Treat cancers: NUV-1511 enters human trials
Disease control OngoingNUV-1511-01 is a first-in human, open- label, Phase 1/2 to evaluate the safety and efficacy of NUV-1511 in patients with advanced solid tumors. The Phase 1 portion include patients with advanced solid tumors and is designed to determine the safety and the tolerability of doses of…
Phase: PHASE1, PHASE2 • Sponsor: Nuvation Bio Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New epilepsy drug shows promise in reducing seizures
Disease control Recruiting nowThe purpose of this study is to determine whether BHV-7000 is effective in the treatment of refractory focal epilepsy.
Phase: PHASE2, PHASE3 • Sponsor: Biohaven Therapeutics Ltd. • Aim: Disease control
Last updated Jun 27, 2026 12:28 UTC
-
Phone app could stop PTSD and pot addiction after assault
Prevention Recruiting now683,000 women are sexually assaulted annually in the United States, half of whom develop chronic posttraumatic stress disorder (PTSD) and thus have markedly increased risk for cannabis use disorder (CUD). The current proposal will test the acceptability, initial efficacy, and mec…
Phase: PHASE1, PHASE2 • Sponsor: University of Nevada, Las Vegas • Aim: Prevention
Last updated Jun 27, 2026 08:11 UTC
-
Promising lupus drug anifrolumab now tested in kids
Disease control Recruiting nowA Study to Evaluate the Pharmacokinetics (PK), Pharmacodynamics (PD), Efficacy, and Safety of Anifrolumab in Children with Moderate to Severe Active Systemic Lupus Erythematosus (SLE)
Phase: PHASE3 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
New drug could reverse liver scarring in MASH patients
Disease control Recruiting nowThe study will assess the efficacy and safety of 2 dose regimens of pegozafermin compared to placebo for the treatment of liver fibrosis stage F2 or F3 in adult participants with MASH.
Phase: PHASE3 • Sponsor: 89bio, Inc. • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
New hope for kids with Crohn's: drug trial targets gut healing
Disease control Recruiting nowThe purpose of this study is to evaluate the clinical and endoscopic efficacy of guselkumab in pediatric participants with Crohn's Disease (CD) at the end of maintenance therapy (Week 52) among participants who were in clinical response to guselkumab at Week 12.
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New drug hope for kids with Crohn's: mirikizumab enters final testing
Disease control Recruiting nowStudy participants will be screened during the platform study and randomly assigned to receive mirikizumab or another intervention. The purpose of the mirikizumab study is to evaluate efficacy, safety, tolerability, and how well mirikizumab absorbs into the body of pediatric part…
Phase: PHASE3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New hope for Hard-to-Treat lymphoma: experimental drug DZD8586 enters phase 2 trial
Disease control OngoingThis study will treat patients with DLBCL whose disease comes back or is not responding to prior therapy. This study will assess the anti-tumor activity of DZD8586 as monotherapy. It will help to understand what type of side effects may occur with the drug treatment. It will also…
Phase: PHASE2 • Sponsor: Dizal Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Can a herbal oil shield cancer patients from chemo nerve pain?
Prevention Recruiting nowThe clinical trial is planned as a prospective, multicentre, blinded, randomised, placebo-controlled, national clinical trial in Germany. The clinical trial is designed for testing the prophylactic and therapeutic effects of Aconite pain oil as compared to placebo in oncological …
Phase: PHASE3 • Sponsor: WALA Heilmittel GmbH • Aim: Prevention
Last updated Jun 26, 2026 13:13 UTC
-
New obesity drug cocktail aims to melt fat, not muscle
Disease control OngoingThis study is researching experimental drugs called trevogrumab and garetosmab (called "study drugs") in combination with another drug, semaglutide (Wegovy®). This study will be done in 3 parts, Part A, Part B, and Part C where different study drugs will be tested. Part A of the…
Phase: PHASE2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 23, 2026 00:00 UTC
-
Radiation-Free breast cancer treatment? new trial tests skipping it after chemo success
Disease control Recruiting nowTo de-escalate radiation therapy in women with breast cancer.
Sponsor: Ontario Clinical Oncology Group (OCOG) • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC